The Seattle Network for Influenza and Flu-Like Symptoms (SNIFLS) at the Chu Lab is working to track viruses like influenza, ...

Among the viruses circulating most are COVID-19, flu and RSV. So far this season, the CDC estimates, there have been at least 24 million flu illnesses, 310,000 hospitalizations and 13,000 deaths ...

A narrowing of the smallest airways in the lung (bronchioles) causes wheezing. This narrowing results from swelling caused by a virus. The respiratory syncytial virus (RSV) causes most bronchiolitis.

A narrowing of the smallest airways in the lung (bronchioles) causes wheezing. This narrowing results from swelling caused by a virus. The respiratory syncytial virus (RSV) causes most bronchiolitis.

GSK has become the first pharma company to get regulatory approval for a vaccine against respiratory syncytial virus (RSV), setting up what looks set to be a highly lucrative – and likely ...

Young children with RSV aged 1 to less than 5 years had low hospitalization rates but high rates of primary care usage. Respiratory syncytial virus (RSV) infection that is managed via primary care in ...

A study today in JAMA Network Open from the University of California, San Francisco (UCSF), shows a high uptake of respiratory syncytial virus (RSV) vaccine and the RSV-preventing monoclonal antibody ...

Sanofi is trailing behind GSK and Pfizer when it comes to vaccines for respiratory syncytial virus (RSV), but it still thinks it can be the top player in the market with a combination of its ...

The United Kingdom swab and viral transport medium market is projected to experience consistent growth, reaching a cumulative value of USD 515.2 million by the end of the next ten years. Despite a ...

Participants were observed for two seasons, from August 31, 2021, to December 18, 2023, to evaluate vaccine efficacy, its safety and the increase in antibody levels against RSV-A and RSV-B variants.